ORCA-010
AXP000037.1 · Oncolytic virus
- Platform
- adenovirus (Ad5 Delta-24-RGD with T1 E3/19K mutation)
- Originator
- VU University Medical Center Amsterdam
- Sponsor
- ORCA Therapeutics
Names
| Name | Type | Source |
|---|---|---|
| ORCA-010 | preferred name, code | curator, ncit |
Virus
- Role
- Oncolytic
- Family
- Adenoviridae
- Virus
- human adenovirus 5 (NCBI Taxonomy 28285)
- Strain
- Ad5 Delta-24-RGD (T1)
- Replication
- conditionally replicating
- Modifications
- Delta-24 E1A; RGD fiber; T1 mutation (single adenine insertion in E3/19K)
- Route
- intratumoral
- Source
- evidence
Cross-references
- NCI Thesaurus
- C168607
Approvals
No regulatory approval recorded.
Clinical trials (1)
| Trial | Title | Status | Phase | Start | Primary completion | Enrolment | Conditions |
|---|---|---|---|---|---|---|---|
| NCT04097002 | First in Man Clinical Study to Evaluate Safety and Tolerability of an Oncolytic Adenovirus in Prostate Cancer Patients. | Unknown | Phase 1/2 | 2019-11-12 | 2024-10 | 24 | Adenocarcinoma of the Prostate |
Recent changes
No changes recorded in its trials yet.
Clinical papers
No confirmed clinical papers yet.
Other papers
Preclinical studies, reviews and other papers that name it.
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 33470166 | Oncolytic Adenovirus ORCA-010 Activates Proinflammatory Myeloid Cells and Facilitates T Cell Recruitment and Activation by PD-1 Blockade in Melanoma. | Human gene therapy | 2021 | name in title: ORCA-010 |
| PMID 32301504 | Oncolytic adenovirus ORCA-010 increases the type 1 T cell stimulatory capacity of melanoma-conditioned dendritic cells. | Clinical and experimental immunology | 2020 | name in title: ORCA-010 |
| PMID 25093639 | ORCA-010, a novel potency-enhanced oncolytic adenovirus, exerts strong antitumor activity in preclinical models. | Human gene therapy | 2014 | name in title: ORCA-010 |
Notes
Delta-24-RGD backbone plus the T1 mutation (single adenine insertion in E3/19K) that increases virus release. Phase I/IIa in prostate cancer, NCT04097002.
How to cite
ORCA-010 (AXP000037.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000037.html
Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.